Business
UniQure Seeks FDA Approval for Gene Therapy
UniQure is seeking FDA approval for a gene therapy to treat Huntington's disease, following a public debate with the agency over clinical trial data.
Coverage timeline — 1 article
CNBC
The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data supporting its application.
2026-06-17 16:12 UTC